Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Hologic, Inc. (HOLX) – Hologic, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Hologic (HOLX) trades at $76.01, near its 52-week high, following the completion of its acquisition by Blackstone and TPG in April 2026. The stock's valuation metrics, including a P/E of 31.54 and P/S of 4.16, reflect a premium pricing. Recent earnings showed mixed results, with beats in Q2 and Q3 2025 but a miss in Q4. The company maintains solid profitability with a 51.47% gross margin and 13.18% net margin, while generating strong operational cash flow of $1.29B in 2024.
The investment outlook is dominated by the completed go-private transaction, limiting public market upside. While Hologic demonstrates fundamental strength in women's health diagnostics and surgical segments, the primary risk for public shareholders is the lack of further appreciation potential post-acquisition. Analyst sentiment remains mixed with 42.86% buy ratings, but the stock now trades near its acquisition price, suggesting limited near-term catalysts for public investors.
Read full analysis

Key Stats

  • Market Cap
    $16.97B
  • Sector
    Health
  • 3M Drawdown
    -0.92%
  • Enterprise Value
    $17.12B
  • Dividend Yield
    -
  • Typical Hold Time
    57 days
$76.01
52W Low: $52.73
05 May 2025
52W High: $76.01
24 Apr 2026

Hologic, Inc. (HOLX) is currently valued at a market capitalization of $16.97B, with an enterprise value of $17.12B. Over the past 52 weeks, Hologic, Inc. has traded between a low of $52.73 and a high of $76.01, highlighting its annual price range. Over the past three months, Hologic, Inc. has recorded a drawdown of -0.92%, reflecting recent price volatility. On average, investors hold Hologic, Inc. for approximately 57 days, indicating typical investor behavior on the platform.

About Hologic, Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.


Technical Indicators
|
|
|
Overall Summary
Bearish (12)Neutral (3)Bullish (8)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $16.97B
  • Sector
    Health
  • 3M Drawdown
    -0.92%
  • Enterprise Value
    $17.12B
  • Dividend Yield
    -
  • Typical Hold Time
    57 days
$76.01
52W Low: $52.73
05 May 2025
52W High: $76.01
24 Apr 2026

Hologic, Inc. (HOLX) is currently valued at a market capitalization of $16.97B, with an enterprise value of $17.12B. Over the past 52 weeks, Hologic, Inc. has traded between a low of $52.73 and a high of $76.01, highlighting its annual price range. Over the past three months, Hologic, Inc. has recorded a drawdown of -0.92%, reflecting recent price volatility. On average, investors hold Hologic, Inc. for approximately 57 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!